DOT1L: A Key Target in Normal Chromatin Remodeling and in Mixed-Lineage Leukemia Treatment
Epigenetics - United States
doi 10.1080/15592294.2019.1699991
Full Text
Open PDFAbstract
Available in full text
Date
December 28, 2019
Authors
Publisher
Informa UK Limited